Results of increasing doses of hydrochlorothiazide in combination with an angiotensin receptor blocker in patients with uncontrolled hypertension [0.03%]
不同剂量氢氯噻嗪与血管紧张素受体阻滞剂联用治疗难治性高血压患者的疗效分析
Steen Neldam,Colin Edwards;Telmisartan/Hydrochlorothiazide Investigators
Steen Neldam
This study examined the effects of increasing the thiazide diuretic dose in a fixed-dose ARB/diuretic combination in patients with uncontrolled hypertension despite 6 weeks' open-label treatment with the ARB/diuretic combination, telmisarta...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Aug;10(8):612-8. DOI:10.1111/j.1751-7176.2008.08187.x 2008
Effect of socioeconomic status on food availability and cost of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern [0.03%]
社会经济地位对高血压饮食模式(DASH)饮食可及性和成本的影响
Christopher M Young,Bryan C Batch,Laura P Svetkey
Christopher M Young
The authors assessed food availability and cost of the Dietary Approaches to Stop Hypertension (DASH) dietary pattern and patients' opinion concerning diet and blood pressure by surveying grocery stores and clinic patients in low- and high-...
A comparison of the blood pressure changes of lumiracoxib with those of ibuprofen and naproxen [0.03%]
Lumiracoxib与ibuprofen和naproxen对血压影响的比较研究
Michael E Farkouh,Freek W A Verheugt,Sean Ruland et al.
Michael E Farkouh et al.
The 52-week Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET) investigated the gastrointestinal and cardiovascular safety profile of lumiracoxib 400 mg once daily compared with 2 traditional nonsteroidal anti-inflamma...
Randomized Controlled Trial
Journal of clinical hypertension (Greenwich, Conn.). 2008 Aug;10(8):592-602. DOI:10.1111/j.1751-7176.2008.07802.x 2008
Overcoming racial and ethnic disparities in blood pressure control: a patient-centered approach to cross-cultural communication [0.03%]
以患者为中心的跨文化沟通方法在克服高血压种族和族裔差异中的作用
Michael J Bloch,Joseph Betancourt,Alex Green
Michael J Bloch
“It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.”—William Osler
Treating hypertension in the oldest of the old reduces total mortality: results of the Hypertension in the Very Elderly Trial (HYVET) [0.03%]
Michael J Bloch,Jan N Basile
Michael J Bloch
Lizzy M Brewster,Gert A van Montfrans
Lizzy M Brewster
Aynur Okcay,Virend K Somers,Sean M Caples
Aynur Okcay
There has long been a recognized link between obstructive sleep apnea (OSA) and the cardiovascular system, no aspect of which has been more studied than blood pressure. Research in OSA has not only demonstrated dysregulation of homeostatic ...
Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension [0.03%]
钾、镁和钙在高血压发病机制及治疗中的作用
Mark C Houston,Karen J Harper
Mark C Houston
Despite advances in the prevention and treatment of hypertension over the past decade, hypertension remains an important public health challenge. Recent efforts to reduce the prevalence of hypertension have focused on nonpharmacologic means...
Michael J Bloch,Jan N Basile
Michael J Bloch
Thomas G Pickering,Lynn Clemow
Thomas G Pickering
This paper reviews the limited literature on paroxysmal hypertension. A case report describes the clinical picture frequently seen in specialty hypertension practice, a patient with paroxysmal or intermittent hypertension who proves not to ...